An over-the-counter nasal spray meant to prevent fatal opioid overdoses could reach shelves early next year. The Food and Drug Administration has reportedly fast-tracked the approval process of an OTC naloxone spray from Emergent BioSolutions, the developers of Narcan. The FDA is expected to make a decision on its…
